Find the best CNRS technologies to boost your innovative project.
30.01.2020
11827-01
06.11.2018
Materials – Coating 07293-01
06.11.2018
Materials – Coating 10581-01
06.11.2018
Chemistry / Environment 08758-01
06.11.2018
11127-01
06.11.2018
Environment and Energy 11107-01
We can guide you through the whole technology transfer process.
Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.
04703-01
Priority patent FR1257598 filed on 03/08/2012. Entitled “Nouveaux composés activateurs de l’activité enzymatique de Sirt1 et compositions phamaceutiques ou cosmétiques les comprenant”
EP13765519.7 filed on 02/08/2013
Joanna Bakala
Jérôme Bignon
Jian-Miao Liu
Maria-Conception Achab
Catherine Guillou
Exclusive or non-exclusive licenses, Collaborative agreement
ICSN, (UPR2301, CNRS) Gif sur Yvette, France.
The sirtuin family concerns nuclear NAD+ dependant deacetylases, playing an important role in deacetylation of histones.
Sirtuin 1 is the best known situin. It is involved in an important number of metabolic processes. It has several target as p53, FoxO, PPAR gamma, PGC1 alpha, UCP2, LXR and Ku70, key regulating proteins in cell functions.
Sirt1 has a global anti-aging effect.
The Sirt1 expression decreases along the lifetime.
Sirt1 has also a role in adipogenesis and lipid accumaltions. The lipolysis is increased by activating Sirt1 activity.
The invention concerns new natural compounds, with a steroid structure, for dermo-cosmetic applications.
These compounds are vegetal steroides.
They show a stimulation activity towards the enzyme Sirtuin 1 (Sirt1), involved in lipid metabolism and aging.
In vitro experiments showed that the compounds are able to inhibit adipogenesis, to enhance lipolysis, and that they have an anti-inflammatory effect.
As vegetal steroid, tests have been made to check their potential interactions with eostrogen and testosteron receptors. The study showed that no interaction occurs with these receptors and undesirable side effects should thus be limited.
A study on model animal (sirt Knock out mice) showed that the compounds had no effect on the animals and that the activity of the compounds is 90% dedicated to Sirt1 activation.
These new compounds could have an interest for cellulite treatment and sub-cutaneous accumulations and the related inflammation.
They could be incorporated in cosmetic preparations to slow the skin aging process.
For further information, please contact us (Ref 04703-01)
28.10.2016
Other Technologies 03239-01
27.07.2015
Health / Therapeutic, Other Technologies 01418-01
11.12.2014
Other Technologies 07921-0108246-01
30.01.2020
11827-01
06.11.2018
Materials – Coating 07293-01
06.11.2018
Materials – Coating 10581-01
06.11.2018
Chemistry / Environment 08758-01
06.11.2018
11127-01
06.11.2018
Environment and Energy 11107-01